Maravai LifeSciences Holdings Inc [NASDAQ: MRVI] loss -3.19% or -0.13 points to close at $3.95 with a heavy trading volume of 4836423 shares.
The daily chart for MRVI points out that the company has recorded -57.25% loss over the past six months.
If we look at the average trading volume of 1.84M shares, MRVI reached to a volume of 4836423 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Maravai LifeSciences Holdings Inc [MRVI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MRVI shares is $8.98 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MRVI stock is a recommendation set at 2.13. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Maravai LifeSciences Holdings Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on December 19, 2024. The new note on the price target was released on December 05, 2024, representing the official price target for Maravai LifeSciences Holdings Inc stock.
The Average True Range (ATR) for Maravai LifeSciences Holdings Inc is set at 0.35, with the Price to Sales ratio for MRVI stock in the period of the last 12 months amounting to 3.60. The Price to Book ratio for the last quarter was 1.62, with the Price to Cash per share for the same quarter was set at 2.29.
Trading performance analysis for MRVI stock
Maravai LifeSciences Holdings Inc [MRVI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.28. With this latest performance, MRVI shares dropped by -24.47% in over the last four-week period, additionally sinking by -57.25% over the last 6 months – not to mention a drop of -25.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MRVI stock in for the last two-week period is set at 29.88, with the RSI for the last a single of trading hit 23.28, and the three-weeks RSI is set at 34.19 for Maravai LifeSciences Holdings Inc [MRVI]. The present Moving Average for the last 50 days of trading for this stock 5.13, while it was recorded at 4.09 for the last single week of trading, and 7.39 for the last 200 days.
Maravai LifeSciences Holdings Inc [MRVI]: A deeper dive into fundamental analysis
Maravai LifeSciences Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.94 and a Current Ratio set at 10.74.
An analysis of Institutional ownership at Maravai LifeSciences Holdings Inc [MRVI]
The top three institutional holders of MRVI stocks are: GTCR LLC with ownership of 20.15 million shares, which is approximately 14.8334%. 12 WEST CAPITAL MANAGEMENT LP, holding 13.21 million shares of the stock with an approximate value of $$94.59 million in MRVI stocks shares; and 12 WEST CAPITAL MANAGEMENT LP, currently with $$76.96 million in MRVI stock with ownership which is approximately 8.1224%.
